Is Cosmos Health Inc. (COSM) Halal?

NASDAQ Healthcare United States $12M
✗ NOT HALAL
Confidence: 90/100
Cosmos Health Inc. (COSM) is Not Halal under AAOIFI Standard 21. The company's debt ratio of 85.5% exceeds the 30% threshold, indicating excessive interest-bearing debt relative to market capitalization. Cosmos Health Inc. operates in the Healthcare sector.

Shariah Screening — 5 Standards

Based on financial data from December 2024

Standard Debt Ratio Cash Ratio Receivables Income Status
AAOIFI 85.5%
/ 30%
2.4%
/ 30%
114.9%
/ 30%
0.75%
/ 5%
✗ NOT HALAL
DJIM 85.5%
/ 33%
2.4%
/ 33%
114.9%
/ 33%
0.75%
/ 5%
✗ NOT HALAL
MSCI 21.8%
/ 33%
0.6%
/ 33%
29.2%
/ 33%
0.75%
/ 5%
✓ HALAL
S&P 85.5%
/ 33%
2.4%
/ 33%
114.9%
/ 33%
0.75%
/ 5%
✗ NOT HALAL
FTSE 21.8%
/ 33%
0.6%
/ 33%
29.2%
/ 50%
0.75%
/ 5%
✓ HALAL

Financial Highlights

EPS
$-0.77
P/B Ratio
0.4
EV/EBITDA
-2.5
EV: $31M
Revenue
$54M
Growth: 37.9%
Beta
4.5
High volatility
Current Ratio
1.0

Profitability

Gross Margin 11.4%
Operating Margin -10.6%
Net Margin -31.0%
Return on Equity (ROE) -63.8%
Return on Assets (ROA) -13.0%

Cash Flow & Balance Sheet

Operating Cash Flow-$8M
Free Cash Flow-$9M
Total Debt$12M
Debt-to-Equity91.1
Current Ratio1.0
Total Assets$54M

Price & Trading

Last Close$0.32
50-Day MA$0.41
200-Day MA$0.64
Avg Volume834K
Beta4.5
52-Week Range
$0.28
$1.32

About Cosmos Health Inc. (COSM)

CEO
Mr. Grigorios Siokas
Employees
149
Sector
Healthcare
Industry
Medical Distribution
Country
United States
Exchange
NASDAQ
Market Cap
$12M
Currency
USD

Cosmos Health Inc. manufactures, develops, and trades branded nutraceutical products in Greece, Croatia, Bulgaria, the United Arab Emirates, the United Kingdom, and Cyprus. The company offers prescription medications, over-the-counter drugs, medical devices, food supplements, nutraceuticals, cosmetics and other healthcare products under the Sky Premium Life and Mediterranation brand names. It also provides ASTO-CHOL (Pravastatin), Diorium (Omeprazole), HEART-FREE (Clopidogrel), LIPICHOL (Atorvastatin), Miltus (Donepezil), Newzypra (Olanzapine), PNEUMO-KAST (Montelukast), Sahar (Pioglitazone), VIVALCID (Leucovorin), and Diabit-is (Sitagliptin). In addition, the company offers branded biocides and antiseptic soaps under the C-Sept and C-Scrub brand names; and other pharmaceutical products include Melatonin Spray, used to reduce insomnia and jet lag; Otikon ear drops, which is a Class II medical device in the form of ear drops; and baby foods, such as organic powder milk, pasta with minced meat, whole grain rice cereals, whole grain cereal porridges, and organic rice creams with vanilla milk, as well as pear, carrot and banana purée under the Bio-bebe brand. It serves wholesalers and retail healthcare providers. Cosmos Health Inc. was incorporated in 2009 and is headquartered in Chicago, Illinois.

Related Halal Stocks in Healthcare

Frequently Asked Questions

Is Cosmos Health Inc. (COSM) halal to invest in?

Based on our screening using AAOIFI Standard 21 (the strictest methodology), Cosmos Health Inc. is Not Halal. The company fails one or more screening criteria. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.

What is Cosmos Health Inc.'s debt ratio?

Cosmos Health Inc.'s debt ratio is 85.5% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 21.8%.

What are Cosmos Health Inc.'s key financial metrics?

Cosmos Health Inc. has a market capitalization of $12M, and revenue of $54M. The company maintains a gross margin of 11.4% and a net margin of -31.0%. Return on equity stands at -63.8%.

How often is the screening data updated?

Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.

Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.